Congress 2014 has ended
Saturday, May 3 • 4:00pm - 5:30pm
Position Your Hormone-Sensitive Patients With Breast Cancer for Success: Understanding Endocrine Therapy Options

Sign up or log in to save this to your schedule and see who's attending!

Endocrine therapy options currently include ovarian suppression along with three main classes of drugs: the selective estrogen receptor modulators (tamoxifen and toremifene), an estrogen receptor antagonist (fulvestrant), and the aromatase inhibitors (letrozole, anastrozole, and exemestane). Learn how the specific choice of therapy depends upon the stage of disease, prior therapy, and the menopausal status of the patient. By the session’s end, you’ll have gained a thorough understanding of endocrine therapy, the backbone of hormone receptor positive breast cancer therapy.

1. Understand the emerging treatment options, including endocrine therapy, for breast cancer.  
2. Describe the implications of these treatment options for nursing practice. 

This session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.  

OCN®: Treatment Modalities
CBCN®: Treatment Modalities:  Local and Systemic
AOCNP®: Cancer Treatment
AOCNS®: Cancer Treatment 

avatar for Carolyn Lavender, RN, MSN, ARNP, AOCNP®

Carolyn Lavender, RN, MSN, ARNP, AOCNP®

Carolyn Lavender has more than 25 years of oncology nursing experience in diverse settings. Her previous clinical experience includes work in pediatric oncology at St. Jude Children’s Research Hospital, adult oncology at H. Lee Moffitt Cancer Center, and adult community care at... Read More →

Michelle Mintz, RN, ARNP-BC, OCN®

Florida Cancer Specialists and Research Institute
Full disclosure: Nothing to disclose.

Saturday May 3, 2014 4:00pm - 5:30pm
Ballroom C Anaheim Convention Center, 800 W. Katella Avenue. Anaheim, CA 92802

Attendees (0)